75N94020D00021 - 75N94023F00001 - ovaprene phase 1: protocol finalization, regulatory approval, start-up, and commencement of recruitment, screening, and enrollment for the ovaprene vaginal device…
Ended Awarded Last action
- Contract number
- 75N94023F00001
- Awardee
-
University Of Utah UEI LL8GLEVH6MG3
- Awarding agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Obligated
- $141,890
Award facts
- Contract value 100% obligated
- $141,890.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 16 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Salt Lake City, UT 84112, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $141,890 |
About this award
The National Institute of Child Health and Human Development (NICHD), a civilian federal agency, has awarded a $141,890 cost-plus-fixed-fee delivery order contract to the University of Utah's Office of Sponsored Projects Division. The contract is for the finalization of the protocol, regulatory approval, start-up, and commencement of recruitment, screening, and enrollment for the Ovaprene vaginal device clinical trial. The contract has an ultimate completion date of December 31, 2025. The University of Utah is a major recipient of federal funding and conducts cutting-edge research across numerous scientific and medical disciplines. This contract award demonstrates the university's capabilities in biomedical research and healthcare services, particularly in supporting research on women's reproductive health.
Description
75N94020D00021 - 75N94023F00001 - ovaprene phase 1: protocol finalization, regulatory approval, start-up, and commencement of recruitment, screening, and enrollment for the ovaprene vaginal device clinical trial
Quick answers
Who was awarded contract 75N94023F00001?
75N94023F00001 was awarded to University Of Utah by National Institute of Child Health and Human Development (National Institutes of Health) on September 28, 2023.
How much is contract 75N94023F00001 worth?
The government has obligated $141,890 on 75N94023F00001.
Is contract 75N94023F00001 an order under another contract?
Yes. 75N94023F00001 is a delivery order under 75N94020D00021, an indefinite delivery contract.
Was contract 75N94023F00001 competed?
The extent of competition for 75N94023F00001 was full and open competition. The government received 16 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award